Company news
Sunshine Biopharma Inc. news in 2021
Sunshine Biopharma Inc.'s news releases, calls and decks from 2021, newest first.
Sunshine Biopharma Announces $1,361,000 in Debt Reduction
December 21, 2021
Sunshine Biopharma Expands Board of Directors
November 2, 2021
Sunshine Biopharma Files a Patent Application Covering mRNA Molecules for Treatment of Neurodegenerative Diseases
October 5, 2021
Sunshine Biopharma’s Coronavirus Treatment Anticipated to be Effective Against Delta and the Other Variants of Concern
August 11, 2021
Sunshine Biopharma Opens Twitter Account For Increased Shareholder Engagement
July 26, 2021
Sunshine Biopharma Receives $0.9 Million in Additional Funding From RB Capital
July 19, 2021
Sunshine Biopharma Employs mRNA Vaccine Technology to Expand Its Fight Against Multidrug Resistant Cancer
July 7, 2021
Sunshine Biopharma Mice Study for COVID-19 Treatment Progressing as Planned
June 8, 2021
Sunshine Biopharma’s Adva-27a Destroys Cancer Cells Expressing P-glycoprotein, a Marker Present in Over 50% of All Cancer Types
May 24, 2021
Sunshine Biopharma Eliminates $250,000 in Variable Rate Convertible Debt and Provides an Update on Status of OTCQB Uplisting
May 19, 2021
Sunshine Biopharma Reports Improved Cash Position in 2021Q1 Filing
May 12, 2021
Sunshine Biopharma Upgrades COVID-19 Provisional Patent Application to Full PCT Application
May 3, 2021
RB Capital Increases Investment in Sunshine Biopharma
April 21, 2021
Sunshine Biopharma Reports Favorable MTD Results for COVID-19 Treatment
April 18, 2021
Sunshine Biopharma Reaches $2,000,000+ Financing for Coronavirus Treatment
March 22, 2021
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Europe Until 2033
March 10, 2021
Sunshine Biopharma Receives Recently Ordered New Batch of Adva-27a and Initiates QA/QC Testing
March 3, 2021
Sunshine Biopharma Launches eCommerce Store for Its Science-Based Nutritional Supplements
February 28, 2021
Sunshine Biopharma Discusses the Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast
February 16, 2021
Sunshine Biopharma Initiates COVID-19 Treatment Mice Study
February 9, 2021
Sunshine Biopharma Signs Exclusive License Agreement With University of Georgia for COVID-19 Compounds
February 3, 2021
Sunshine Biopharma Receives Notice of Allowance for a New Patent Application Extending Protection of Adva-27a in Canada Until 2033
February 1, 2021
Sunshine Biopharma Completes Application to Uplist to OTCQB
January 26, 2021
Sunshine Biopharma Receives Fourth Tranche From Previously Announced $2,000,000 + Financing for Coronavirus Treatment
January 13, 2021